SUMMARY
TrialScope Disclose includes a set of standard assessment and due date rules that can be enabled/disabled which help customers comply with their obligation to disclose clinical trial information. For IPRMA PMS (Taiwan), TrialScope Disclose includes the following rules:
Assess if Protocol Registration is needed on IPRMA PMS (Taiwan) for post-market surveillance studies
Initial Protocol Law Due Date on IPRMA PMS (Taiwan)
Assessments
Assess if Protocol Registration is needed on IPRMA PMS (Taiwan) for post-market surveillance studies
Post Market Surveillance Studies started since September 1, 2009, with locations in Taiwan will be automatically assessed to register on the TMS Registry after protocol approval by the IRB.
Compliance Events & Due Dates
Initial Protocol Law Due Date on IPRMA PMS (Taiwan)
The Taiwan IRPMA PMS (Taiwan) Protocol is assessed, study needs to be registered 30 days after IRB Approval Date.